Visit www.MesotheliomaWebDirectory.com Today!:Allos Therapeutics, Inc. (ALTH) Initiates Phase 1 PDX Study

Allos Therapeutics, Inc. today announced the initiation of a Phase 1 dose escalation study of its investigational drug PDX (pralatrexate) with vitamin B12 and folic acid supplementation in patients with previously-treated (Stage IIIB-IV) advanced non-small cell lung cancer (NSCLC). This open-label, non-randomized study will seek to enroll one to six ... more...

MesotheliomaWebDirectory
Originally Posted on 6/4/2005 9:32:00 PMContent source: http://www.asbestos-class-action.info/index.php/2005/01/allos-therapeutics-inc-alth-initiates-phase-1-pdx-study/